However, TDP‐43 aggregates were also present in the amygdala in Patient 1, and areas of executive, language/fluency, sensory, and memory function in Patient 2, despite there being no cognitive impairment in these domains, indicating resilience to TDP‐43 pathology in these areas and specificity but not sensitivity of TDP‐43 pathology to cognitive impairment, as shown previously [19] (see Table 3). The gene discussed is TARDBP; the disease is Cognitive impairment.